A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Stay informed on the latest developments in the Alzheimer's Disease market and potential FDA Accelerated Approvals with Vigil ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

Whether you have known vision issues or not, there are several reasons why it's important to prioritize your eye health, as your vision has implications for the health of your body as a whole. Here, ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, talked with UVA Today about the newest study and shared ways people can ...

Residents of Martin County are invited to join the inaugural meeting of the Dementia Friendly Martin County Action Team on Tuesday, ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Researchers demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid later in life, potentially predisposing them to late-onset brain amyloid disorders, ...